Trial reportTelemedicine journal and e-health : the official journal of the American Telemedicine Association2014
The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction.
Trial report in Telemedicine journal and e-health : the official journal of the American Telemedicine Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Cardiovascular Intervention Improvement Telemedicine Study
"The Community Pharmacist and the Case Management of Diabetic Patient" - No Profit Observational Study on the Role of the Community Pharmacist and the "Pharmacy of the Services" in the Diabetic Patient Case Management
Who cites it
15 citing papers in PubMed, 24 citations in OpenAlex.
- A Web-Based Self-Titration Program to Control Blood Pressure in Patients With Primary Hypertension: Randomized Controlled Trial.Journal of medical Internet research · 2019Trial
- Patient-reported medication adherence barriers among patients with cardiovascular risk factors.Journal of managed care & specialty pharmacy · 2015Trial
- The Effect of Health Education by Pharmacists on 10-Year Atherosclerotic Cardiovascular Disease Risk: A Cluster-Randomized Control Study in a Low Socioeconomic Status Javanese Population.Journal of primary care & community healthTrial
- Knowledge and acceptance associated with medication adherence among hypertension individuals in Aceh province, Indonesia.Heliyon · 2024Article
- Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.Journal of managed care & specialty pharmacy · 2023Article
- Lessons learned from two randomized controlled trials: CITIES and STOP-DKD.Contemporary clinical trials communications · 2020Article
- Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis.BMC rheumatology · 2020Article
- Opportunities to Leverage Telehealth Approaches Along the Hypertension Control Cascade in Sub-Saharan Africa.Current hypertension reports · 2019Review
- Enrollment and Retention of Men and Women in Health Services Research and Development Trials.Women's health issues : official publication of the Jacobs Institute of Women's Health · 2019Article
- Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).Contemporary clinical trials · 2019Article
- Credentialing in Pharmacy Practice: Examining Pharmacist Views and Perceptions.Innovations in pharmacy · 2019Article
- Impact of Gender on Satisfaction and Confidence in Cholesterol Control Among Veterans at Risk for Cardiovascular Disease.Journal of women's health (2002) · 2017Article
- Endocrinology Telehealth Consultation Improved Glycemic Control Similar to Face-to-Face Visits in Veterans.Journal of diabetes science and technology · 2016Article
- Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.Journal of managed care & specialty pharmacy · 2016Article
- Behavioral interventions to improve hypertension control in the Veterans Affairs healthcare system.Journal of clinical hypertension (Greenwich, Conn.) · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundHypertension, hyperlipidemia, and diabetes are significant, but often preventable, contributors to cardiovascular disease (CVD) risk. Medication and behavioral nonadherence are significant barriers to successful hypertension, hyperlidemia, and diabetes management. Our objective was to describe the theoretical framework underlying a tailored behavioral and educational pharmacist-administered intervention for achieving CVD risk reduction. MATERIALS AND
methodsAdults with poorly controlled hypertension and/or hyperlipidemia were enrolled from three outpatient primary care clinics associated with the Durham Veterans Affairs Medical Center (Durham, NC). Participants were randomly assigned to receive a pharmacist-administered, tailored, 1-year telephone-based intervention or usual care. The goal of the study was to reduce the risk for CVD through a theory-driven intervention to increase medication adherence and improve health behaviors.
resultsEnrollment began in November 2011 and is ongoing. The target sample size is 500 patients.
conclusionsThe Cardiovascular Intervention Improvement Telemedicine Study (CITIES) intervention has been designed with a strong theoretical underpinning. The theoretical foundation and intervention are designed to encourage patients with multiple comorbidities and poorly controlled CVD risk factors to engage in home-based monitoring and tailored telephone-based interventions. Evidence suggests that clinical pharmacist-administered telephone-based interventions may be efficiently integrated into primary care for patients with poorly controlled CVD risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.